5,7-dihydroxytryptamine has been researched along with Idiopathic Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kostrzewa, JP; Kostrzewa, RM | 1 |
| Hu, LF; Liu, CF; Liu, JY; Lv, DJ; Mao, CJ; Wang, CT; Wang, F; Xia, KL; Xu, GY; Yang, YP; Zhang, CY; Zhang, XQ | 1 |
| Brundin, P; Cenci, MA; Lane, EL | 1 |
| Daszuta, A; Di Cara, B; Kerkerian-Le Goff, L; Salin, P; Samuel, D | 1 |
| Björklund, A; Carlsson, T; Carta, M; Kirik, D | 1 |
| Jonsson, G | 1 |
1 review(s) available for 5,7-dihydroxytryptamine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Chemical neurotoxins as denervation tools in neurobiology.
Topics: 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine; Animals; Benzylamines; Brain; Catecholamines; Denervation; Dopamine; Glutamates; Humans; Hydroxydopamines; Ibotenic Acid; Kainic Acid; Neurotoxins; Neurotransmitter Agents; p-Chloroamphetamine; Parkinson Disease; Rats; Receptors, Neurotransmitter; Schizophrenia; Serotonin | 1980 |
5 other study(ies) available for 5,7-dihydroxytryptamine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson's Disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Animals; Animals, Newborn; Dopamine; Exocytosis; Female; Male; Microdialysis; Neostriatum; Oxidopamine; p-Chloroamphetamine; Parkinson Disease; Rats; Serotonin | 2020 |
Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Animals; Disease Models, Animal; gamma-Aminobutyric Acid; Hyperalgesia; Indoles; Male; Medulla Oblongata; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Signal Transduction; Spinal Cord; Sympatholytics; Tyrosine 3-Monooxygenase | 2017 |
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine Uptake Inhibitors; Dyskinesias; Embryo, Mammalian; Female; Levodopa; Mesencephalon; Oxidopamine; Parkinson Disease; Pregnancy; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Transplants; Tyrosine 3-Monooxygenase | 2009 |
Serotonergic regulation of the GABAergic transmission in the rat basal ganglia.
Topics: 5,7-Dihydroxytryptamine; Animals; Basal Ganglia; Extracellular Fluid; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Isoenzymes; Membrane Potentials; Neural Inhibition; Neural Pathways; Neurons; Parkinson Disease; Rats; Rats, Wistar; RNA Processing, Post-Transcriptional; RNA, Messenger; Serotonin; Synaptic Transmission | 2003 |
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Agents | 2007 |